1. Department of Hematology and Central Hematology Laboratory, Inselspital/Bern University Hospital, and
2. Department for BioMedical Research, University of Bern, Bern, Switzerland;
3. Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland;
4. Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
5. Swiss Patient Safety Foundation, Zurich, Switzerland;
6. Institute of Social and Preventive Medicine (ISPM) and
7. Department of Medical Oncology, Inselspital/Bern University Hospital, University of Bern, Bern, Switzerland;
8. Department of Hematology, Leeds Teaching Hospitals, Leeds, United Kingdom;
9. Department of Clinical Hematology, Institute of Hematology and Blood Transfusion, Prague, Czech Republic;
10. Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands;
11. Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands;
12. Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands;
13. Department of Physiotherapy, Bern University Hospital, Bern, Switzerland;
14. Hôpital St. Louis, Assistance Publique–Hôpitaux de Paris/Paris University, Paris, France;
15. Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany;
16. Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Bern University Hospital, and
17. Institute of Pharmacology, University of Bern, Bern, Switzerland;
18. Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska University Hospital, Huddinge, Stockholm, Sweden;
19. Department of Hematology, University Hospital Basel, Basel, Switzerland;
20. 3rd Medical Department, Hanusch Hospital, Vienna, Austria;
21. Medical Clinic and
22. Policlinic 1, Hematology and Cellular Therapy, Leipzig University Hospital, Leipzig, Germany;
23. Department of Molecular Medicine, University of Pavia, Pavia, Italy;
24. Hematology Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) S. Matteo Hospital, Pavia, Italy;
25. Hospital da Luz, Lisboa, Portugal;
26. Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv-Yafo, Israel;
27. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
28. MDS Unit, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy;
29. Fondazione Italiana Sindromi Mielodisplastiche (FISiM), Florence, Italy;
30. Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria;
31. Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, Greece;
32. SAKK Coordinating Center, Bern, Switzerland; and
33. Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands